SparkSeven Bio Overview

  • Year Founded
  • 2025

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 2

SparkSeven Bio General Information

Description

Developer of antibody discovery technology designed for therapeutic research purposes. The company's platform supports the identification and generation of functional monoclonal antibodies targeting G protein-coupled receptors by addressing structural complexity and conformational variability of membrane proteins through receptor presentation and screening methods, enabling biotechnology and pharmaceutical companies to support antibody-based drug research for multiple disease indications.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Corporate Office
  • Klopferspitz 19 A, MAxL
  • BioM Biotech Cluster Development GmbH
  • 82152 Martinsried
  • Germany
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Life Sciences
Corporate Office
  • Klopferspitz 19 A, MAxL
  • BioM Biotech Cluster Development GmbH
  • 82152 Martinsried
  • Germany

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

SparkSeven Bio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Accelerator/Incubator Completed Startup
1. Accelerator/Incubator Completed Startup
To view SparkSeven Bio’s complete valuation and funding history, request access »

SparkSeven Bio Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
MAxL Accelerator/Incubator
Mission BioCapital Venture Capital Minority
To view SparkSeven Bio’s complete investors history, request access »

Ready to get started?

Request a free trial

SparkSeven Bio FAQs

  • When was SparkSeven Bio founded?

    SparkSeven Bio was founded in 2025.

  • Where is SparkSeven Bio headquartered?

    SparkSeven Bio is headquartered in Martinsried, Germany.

  • What industry is SparkSeven Bio in?

    SparkSeven Bio’s primary industry is Drug Discovery.

  • Is SparkSeven Bio a private or public company?

    SparkSeven Bio is a Private company.

  • What is SparkSeven Bio’s current revenue?

    The current revenue for SparkSeven Bio is .

  • Who are SparkSeven Bio’s investors?

    MAxL and Mission BioCapital have invested in SparkSeven Bio.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process